Back to ROIV
FMR LLC ROIV Position History
Roivant Sciences Ltd. • Healthcare
Quarters held
61
Latest value
$576K
Q3 2026
Peak value
$1.9B
First seen
Q1 2022
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2022 | $12.3M |
| Q2 2022 | $10.2M |
| Q3 2022 | $12.8M |
| Q3 2022 | $610K |
| Q4 2022 | $164.4M |
| Q4 2022 | $78.2M |
| Q1 2023 | $143.5M |
| Q1 2023 | $83.6M |
| Q2 2023 | $232.1M |
| Q2 2023 | $130.4M |
| Q2 2023 | $279K |
| Q3 2023 | $286.3M |
| Q3 2023 | $167.8M |
| Q3 2023 | $414 |
| Q3 2023 | $323K |
| Q3 2023 | $58 |
| Q4 2023 | $253.1M |
| Q4 2023 | $162M |
| Q4 2023 | $1K |
| Q4 2023 | $116K |
| Q1 2024 | $219.9M |
| Q1 2024 | $152.6M |
| Q2 2024 | $277.2M |
| Q2 2024 | $214.8M |
| Q2 2024 | $529 |
| Q3 2024 | $317.9M |
| Q3 2024 | $249.2M |
| Q3 2024 | $11K |
| Q4 2024 | $318.2M |
| Q4 2024 | $265M |
| Q4 2024 | $24K |
| Q1 2025 | $283.2M |
| Q1 2025 | $238.1M |
| Q1 2025 | $19K |
| Q3 2025 | $512.9M |
| Q3 2025 | $405.4M |
| Q3 2025 | $465K |
| Q3 2025 | $517K |
| Q3 2025 | $65K |
| Q4 2025 | $815.5M |
| Q4 2025 | $609.8M |
| Q4 2025 | $779K |
| Q4 2025 | $1.2M |
| Q4 2025 | $180K |
| Q1 2026 | $1.3B |
| Q1 2026 | $843.9M |
| Q1 2026 | $1.3M |
| Q1 2026 | $3.7M |
| Q1 2026 | $219K |
| Q2 2026 | $1.7B |
| Q2 2026 | $1.1B |
| Q2 2026 | $6.9M |
| Q2 2026 | $3.5M |
| Q2 2026 | $6.5M |
| Q2 2026 | $328K |
| Q3 2026 | $1.9B |
| Q3 2026 | $1.2B |
| Q3 2026 | $9.9M |
| Q3 2026 | $3.6M |
| Q3 2026 | $7.7M |
| Q3 2026 | $576K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $576K | 15.8K | — | — |
| Q3 2026 | $7.7M | 210.5K | — | — |
| Q3 2026 | $3.6M | 97.6K | — | — |
| Q3 2026 | $9.9M | 270.3K | — | — |
| Q3 2026 | $1.2B | 32.27M | — | — |
| Q3 2026 | $1.9B | 52.71M | — | — |
| Q2 2026 | $328K | 9.3K | — | — |
| Q2 2026 | $6.5M | 183.5K | — | — |
| Q2 2026 | $3.5M | 97.6K | — | — |
| Q2 2026 | $6.9M | 194.2K | — | — |
| Q2 2026 | $1.1B | 31.40M | — | — |
| Q2 2026 | $1.7B | 49.14M | — | — |
| Q1 2026 | $219K | 7.9K | — | — |
| Q1 2026 | $3.7M | 134.9K | — | — |
| Q1 2026 | $1.3M | 47.3K | — | — |
| Q1 2026 | $843.9M | 30.47M | — | — |
| Q1 2026 | $1.3B | 47.32M | — | — |
| Q4 2025 | $180K | 8.3K | — | — |
| Q4 2025 | $1.2M | 54.6K | — | — |
| Q4 2025 | $779K | 35.9K | — | — |
| Q4 2025 | $609.8M | 28.10M | — | — |
| Q4 2025 | $815.5M | 37.58M | — | — |
| Q3 2025 | $65K | 4.3K | — | — |
| Q3 2025 | $517K | 34.2K | — | — |
| Q3 2025 | $465K | 30.8K | — | — |
| Q3 2025 | $405.4M | 26.80M | — | — |
| Q3 2025 | $512.9M | 33.90M | — | — |
| Q1 2025 | $19K | 1.9K | — | — |
| Q1 2025 | $238.1M | 23.60M | — | — |
| Q1 2025 | $283.2M | 28.07M | — | — |
| Q4 2024 | $24K | 2.0K | — | — |
| Q4 2024 | $265M | 22.40M | — | — |
| Q4 2024 | $318.2M | 26.90M | — | — |
| Q3 2024 | $11K | 914 | — | — |
| Q3 2024 | $249.2M | 21.59M | — | — |
| Q3 2024 | $317.9M | 27.55M | — | — |
| Q2 2024 | $529 | 50 | — | — |
| Q2 2024 | $214.8M | 20.33M | — | — |
| Q2 2024 | $277.2M | 26.23M | — | — |
| Q1 2024 | $152.6M | 14.47M | — | — |
| Q1 2024 | $219.9M | 20.87M | — | — |
| Q4 2023 | $116K | 10.4K | — | — |
| Q4 2023 | $1K | 90 | — | — |
| Q4 2023 | $162M | 14.43M | — | — |
| Q4 2023 | $253.1M | 22.54M | — | — |
| Q3 2023 | $58 | 5 | — | — |
| Q3 2023 | $323K | 27.7K | — | — |
| Q3 2023 | $414 | 35 | — | — |
| Q3 2023 | $167.8M | 14.37M | — | — |
| Q3 2023 | $286.3M | 24.51M | — | — |
| Q2 2023 | $279K | 27.7K | — | — |
| Q2 2023 | $130.4M | 12.94M | — | — |
| Q2 2023 | $232.1M | 23.03M | — | — |
| Q1 2023 | $83.6M | 11.32M | — | — |
| Q1 2023 | $143.5M | 19.44M | — | — |
| Q4 2022 | $78.2M | 9.79M | — | — |
| Q4 2022 | $164.4M | 20.58M | — | — |
| Q3 2022 | $610K | 189.5K | — | — |
| Q3 2022 | $12.8M | 3.99M | — | — |
| Q2 2022 | $10.2M | 2.50M | — | — |
| Q1 2022 | $12.3M | 2.50M | — | — |
Other funds holding ROIV
$1.3B
$1.2B
$1.2B
$1.1B
$867.6M